ImmuPharma plc (AIM:IMM)

London flag London · Delayed Price · Currency is GBP · Price in GBX
8.03
-0.30 (-3.60%)
At close: Feb 27, 2026
100.75%
Market Cap 40.37M
Revenue (ttm) n/a
Net Income (ttm) -3.93M
Shares Out 502.72M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 730,171
Average Volume 3,486,306
Open 7.54
Previous Close 8.33
Day's Range 7.52 - 8.78
52-Week Range 1.39 - 19.40
Beta 2.98
RSI 55.90
Earnings Date Apr 24, 2026

About ImmuPharma

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company’s lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired aut... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 6
Stock Exchange London Stock Exchange AIM
Ticker Symbol IMM
Full Company Profile

Financial Performance

Financial Statements

News

AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West

Immupharma, Pebble Beach, Tungsten West, SkinBioTherapeutics and PHSC are today's biggest risers and fallers on London's AIM market

12 days ago - The Armchair Trader

FTSE Flat as Wall Street Gains Fail to Inspire

FTSE mostly flat as housebuilders outperform; ImmuPharma slides, US gains fail to lift London sentiment. The post FTSE Flat as Wall Street Gains Fail to Inspire appeared first on Investomania .

3 months ago - Investomania

AIM Market Roundup: Trellus Health, Great Western Mining, EMV Capital

Trellus Health, Great Western Mining, EMV Capital are today's top risers, while EQTEC, ImmuPharma take the biggest fall on London's AIM

3 months ago - The Armchair Trader

AIM Market Roundup: ImmuPharma, Rockfire Resources, Likewise

ImmuPharma, Rockfire Resources, Likewise are today's top risers, while Trellus Health, Mercantile Ports take the biggest fall on London's AIM

6 months ago - The Armchair Trader

AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals

Dewhurst, Metir, Tertiary Minerals are today's top risers, while LifeSafe, ImmuPharma take the biggest fall on London's AIM market

6 months ago - The Armchair Trader

AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien

Immupharma, N4 Pharma, Versarien are today's top risers, while Wishbone, Empyrean take the biggest fall on London's AIM market

6 months ago - The Armchair Trader

AIM Market Roundup: Catenai, Europa Oil & Gas, Faron Pharma

Catenai, Europa Oil & Gas, Faron Pharma are today's top risers, while Simec Atlantis, Immupharma take the biggest fall on London's AIM market

7 months ago - The Armchair Trader

FTSE Rises as Investors Eye Tariff Deadline

FTSE rises as tariff deadline looms, Hiscox and Faron climb on results, ImmuPharma sinks on losses. The post FTSE Rises as Investors Eye Tariff Deadline appeared first on Investomania .

7 months ago - Investomania

FX positioning info - Net speculative EUR longs surged in a sharp rise from previous week

This is a snapshot of speculative positioning in major currencies from traders in the futures market, reported weekly by the CFTC through the IMM (International Monetary Market). EUR: Net speculative ...

1 year ago - Forexlive

Data show speculative traders have flipped from a net short to a net long position on euro

The IMM CFTC positioning data, released weekly by the Commodity Futures Trading Commission (CFTC), provides insights into how speculative traders, such as hedge funds and large investors, are position...

1 year ago - Forexlive

AIM Market Roundup: Immupharma, Poolbeg, Xeros

ImmuPharma, Poolbeg Pharma, Xeros Technology, RBG Holdings, Coro Energy are today's biggest risers and fallers on London's AIM market

1 year ago - The Armchair Trader

Three Quick Facts: Norman Broadbent, Computacenter, Immupharma

Norman Broadbent, Computacenter, ImmuPharma are Tony Cross's three picks from today's financial market news

1 year ago - The Armchair Trader